ErbB Receptors (genetics) < ErbB Receptors (metabolism) < Erdheim-Chester disease

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by ErbB Receptors (metabolism)

Number of relevant bibliographic references: 8.

Ident.	Authors (with country if any)	Title
000B23 (2019)	Zhirui Zhang [République populaire de Chine] ; Mengxiao Zhang [République populaire de Chine] ; Hao Liu [République populaire de Chine] ; Wu Yin [République populaire de Chine]	AZD9291 promotes autophagy and inhibits PI3K/Akt pathway in NSCLC cancer cells.
000C44 (2018)	Tingting Lv [République populaire de Chine] ; Ziying Li [République populaire de Chine] ; Liang Xu [République populaire de Chine] ; Yingying Zhang [République populaire de Chine] ; Haijun Chen [République populaire de Chine] ; Yu Gao [République populaire de Chine]	Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer.
000D30 (2017)	Tianyu Han [République populaire de Chine] ; Meng Guo [République populaire de Chine] ; Tingting Zhang [République populaire de Chine] ; Mingxi Gan [République populaire de Chine] ; Caifeng Xie [République populaire de Chine] ; Jian-Bin Wang [République populaire de Chine]	A novel glutaminase inhibitor-968 inhibits the migration and proliferation of non-small cell lung cancer cells by targeting EGFR/ERK signaling pathway.
000D63 (2016)	Yan Zhou [États-Unis] ; Yuan Li [États-Unis] ; Hong-Min Ni [États-Unis] ; Wen-Xing Ding [États-Unis] ; Hua Zhong [République populaire de Chine]	Nrf2 but not autophagy inhibition is associated with the survival of wild-type epidermal growth factor receptor non-small cell lung cancer cells.
001029 (2014)	Sivan M. Bokobza [Royaume-Uni] ; Yanyan Jiang ; Anika M. Weber ; Aoife M. Devery ; Anderson J. Ryan [Royaume-Uni]	Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells.
001116 (2013)	Yuji Sakuma [Japon] ; Shoichi Matsukuma ; Yoshiyasu Nakamura ; Mitsuyo Yoshihara ; Shiro Koizume ; Hironobu Sekiguchi ; Haruhiro Saito ; Haruhiko Nakayama ; Yoichi Kameda ; Tomoyuki Yokose ; Sachiko Oguni ; Toshiro Niki ; Yohei Miyagi	Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells.
001473 (2011)	Weidong Han [République populaire de Chine] ; Hongming Pan ; Yan Chen ; Jie Sun ; Yanshan Wang ; Jing Li ; Weiting Ge ; Lifeng Feng ; Xiaoying Lin ; Xiaojia Wang ; Xian Wang ; Hongchuan Jin	EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells.
002E93 (1991)	J P Shaw [États-Unis] ; D E Akiyoshi ; D A Arrigo ; A E Rhoad ; B. Sullivan ; J. Thomas ; F S Genbauffe ; P. Bacha ; J C Nichols	Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "ErbB Receptors (metabolism)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "ErbB Receptors (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    ErbB Receptors (metabolism)
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021